DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Cardiovascular agents; Musculo-Skeletal System; Musculo-Skeletal System are 4




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_1527Indomethacin
Cardiovascular agents; Musculo-Skeletal System; Musculo-Skeletal System
Rheumatoid arthritis | Ankylosing spondylitis | Osteoarthritis | Acute painful shoulder (bursitis and/or tendinitis) | Acute gouty arthritis
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (39.73 %)
Approved, Investigational
27476412
DrugRepV_2879Indomethacin
Cardiovascular agents; Musculo-Skeletal System; Musculo-Skeletal System
Rheumatoid arthritis | Ankylosing spondylitis | Osteoarthritis | Acute painful shoulder (bursitis and/or tendinitis) | Acute gouty arthritis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-8.1963187 %)
Approved, Investigational
27742486
DrugRepV_5544Indomethacin
Cardiovascular agents; Musculo-Skeletal System; Musculo-Skeletal System
Rheumatoid arthritis | Ankylosing spondylitis | Osteoarthritis | Acute painful shoulder (bursitis and/or tendinitis) | Acute gouty arthritis
SARS Coronavirus-2
2019-nCoV/USA-WA1/2020
NA
NA
Decrease (50 %)
Approved, Investigational
32353859
DrugRepV_7545Indomethacin
Cardiovascular agents; Musculo-Skeletal System; Musculo-Skeletal System
Rheumatoid arthritis | Ankylosing spondylitis | Osteoarthritis | Acute painful shoulder (bursitis and/or tendinitis) | Acute gouty arthritis
SARS Coronavirus-2
cDNA used to create pseudotyped virus, GenBank: MN908947.3
NA
Luciferase labelled
Decrease (50 %)
Approved, Investigational
32438446